Kapuściński A
Department of Neuropathology, Polish Academy of Sciences, Warsaw.
Neuropatol Pol. 1992;30(2):127-32.
By means of the radioimmunologic method changes of concentration of 6-keto-prostaglandin F1 alpha (PGF1 alpha)--the stable metabolite of prostacyclin in the rat brain have been evaluated during 5-min clinical death and up to 2 hrs after resuscitation. Ischemia did not produce significant changes of 6-keto-PGF1 alpha concentration in the brain. In the early postresuscitation period the concentration of 6-keto-PGF1 in the and 7-fold control values. Later the concentration of 6-keto-PGF1 alpha in the brain decreased reaching in 30 min a 3-fold the control level, and in 60 and 120 min after resuscitation control values. The reasons of unsuccessful therapy of ischemic stroke with prostacyclin are discussed.
采用放射免疫法,对大鼠大脑中前列环素的稳定代谢产物6-酮-前列腺素F1α(PGF1α)在5分钟临床死亡期间及复苏后长达2小时的浓度变化进行了评估。缺血未引起大脑中6-酮-PGF1α浓度的显著变化。在复苏后的早期,大脑中6-酮-PGF1的浓度比对照值高7倍。随后,大脑中6-酮-PGF1α的浓度下降,在复苏后30分钟降至对照水平的3倍,在复苏后60分钟和120分钟恢复到对照值。文中讨论了前列环素治疗缺血性中风未成功的原因。